PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25026P0084Emergent - pharmaceutical compounding services — Regents of the University of Michigan

Regents of the University of Michigan holds $125.4M across 262 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: Unrestricted. PoP ended Sep 30, 2026 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

250-Network Contract Office 10 (36C250)
Awarding office
Regents of the University of Michigan
Recipient
Sep 30, 2026
PoP end
$124K
Obligated
$124K
Potential
325412
NAICS
Q517
PSC
Unrestricted
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted
Contract number36C25026P0084
Also listed as36C250-26-P-0084
Agency250-Network Contract Office 10 (36C250)
Awarding office250-Network Contract Office 10 (36C250)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentRegents of the University of Michigan
CAGE03399
UEIGNJ7BBP73WE9
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSCQ517
Place of performanceANN ARBOR MI
Pricing typeFirm Fixed Price
Extent competedNot Competed Under SAP
PoP startNov 24, 2025
PoP end (current)Sep 30, 2026
Obligated$124K
Current value$124K
Potential value$124K

EMERGENT - PHARMACEUTICAL COMPOUNDING SERVICES - ANN ARBOR VA MEDICAL CENTER is a federal Unrestricted award for 250-Network Contract Office 10 (36C250) held by Regents of the University of Michigan. Estimated value $124K ($124K obligated). Current period of performance ends Sep 30, 2026. Last award drew 1 bidder. Place of performance: ANN ARBOR MI.

EMERGENT - PHARMACEUTICAL COMPOUNDING SERVICES - ANN ARBOR VA MEDICAL CENTER

Recompete timing

Public
● Past PoP end (0 days ago)

Current PoP ends Sep 30, 2026 (0 days remaining). Agencies typically plan 12–18 months ahead — at 0.0 months out, that window is already open. The buying decision is likely already in motion.

Bonuses end Sept 30

Want the durability read on 36C25026P0084? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Regents of the University of Michigan — $125.4M obligated across 262 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($125.4M) · all agencies · Top 4 shown (89%); remaining ~11% is other agencies.
Department of Health and Human Services (HHS)$44.0M · 35%National Aeronautics and Space Administration (NASA)$32.0M · 26%Department of Defense (DOD)$20.3M · 16%Department of Veterans Affairs (VA)$15.8M · 13%
Open full company profile →

Related awards

Same incumbent
693JJ921F000192
NEW TASK ORDER PURPOSE: TO PUT OUT FOR BID TO CONTRACTS AWARDED FOR THE NEW EXPERIMENTAL A…
$602K
Oct 29, 2026
80NSSC25PA822
EXTRATERRESTRIAL MOLECULAR INDICATORS OF LIFE INVESTIGATION (EMILI) RF ELECTRONICS SYSTEM
$188K
Sep 30, 2026
75FCMC21C0035
THIS DATA INDICATORS PROJECT WILL PROVIDE DETAILED DATA REPORTS ABOUT END STAGE RENAL DISE…
$21.8M
Sep 29, 2026
75F40123C00197
SEAMLESS DESIGN FOR MULTICOMPONENT ENDPOINTS FOR DRUG DEVELOPMENT IN RARE DISEASES
$1.2M
Sep 29, 2026
693JJ922F00162N
THIS IS A NEW NON-SEVERABLE TASK ORDER. THIS FUNDING IS REQUIRED TO ISSUE A RFP FOR A TASK…
$700K
Sep 18, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C25026P0084?

36C25026P0084 (Emergent - pharmaceutical compounding services) is a 250-Network Contract Office 10 (36C250) award with a potential value of $124K, currently held by Regents of the University of Michigan. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C250-26-P-0084?

36C250-26-P-0084 is the dashed form of PIID 36C25026P0084 (Emergent - pharmaceutical compounding services), held by Regents of the University of Michigan. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25026P0084?

250-Network Contract Office 10 (36C250) awarded 36C25026P0084 to Regents of the University of Michigan (potential $124K).

Who is the incumbent on 36C25026P0084?

Regents of the University of Michigan is the incumbent with $125.4M across 262 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.

When does Regents of the University of Michigan’s 36C25026P0084 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 36C25026P0084? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C25026P0084